Monocyte recruitment to sites of inflammation, including atherosclerotic lesions, is dependent on the mechanosensitive ion channel Piezo1JOURNAL OF IMMUNOLOGYIF3.42025-11-010PRE
Atherosclerotic Plaque Macrophages Drive Abdominal Aortic Aneurysm FormationARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGYIF7.42024-05-010PRE
Plasma S1P Orchestrates the Reverse Transendothelial Migration of Aortic Intimal Myeloid Cells in MiceARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGYIF7.42024-04-010PRE
A Novel En Face Ex Vivo Live Imaging Approach For The Visualization Of Intimal Myeloid Cell DynamicsARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGYIF7.42023-05-010PRE
Transcriptomic Analysis Reveals That Intimal Monocytes Drive Inflammation In Early AtherogenesisARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGYIF7.42023-05-010PRE
Colony stimulating factor-1 producing endothelial cells and mesenchymal stromal cells maintain monocytes within a perivascular bone marrow nicheIMMUNITYIF26.32022-05-0135OAAI
Transcriptomic Analysis Reveals That Lipid Loading Of Distinct Intimal Myeloid Cell Subpopulations Precedes Inflammation In Early AtherogenesisARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGYIF7.42022-05-013PRE
Role of myeloid-derived chemokine CCL5/RANTES at an early stage of atherosclerosisJOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGYIF4.72021-07-0121PREAI
Adventitial recruitment of Lyve-1- macrophages drives aortic aneurysm in an angiotensin-2-based murine modelCLINICAL SCIENCEIF7.72021-05-287OA
Radiation Impacts Early Atherosclerosis by Suppressing Intimal LDL AccumulationCIRCULATION RESEARCHIF16.22021-02-1918OA
Self-renewing resident cardiac macrophages limit adverse remodeling following myocardial infarction (vol 20, pg 29, 2018)NATURE IMMUNOLOGYIF27.62019-03-121OAAI
Self-renewing resident cardiac macrophages limit adverse remodeling following myocardial infarctionNATURE IMMUNOLOGYIF27.62018-12-11582OAAI
CCL19-CCR7 dependent reverse transendothelial migration of myeloid cells clears Chlamydia muridarum from the arterial intimaNATURE IMMUNOLOGYIF27.62016-09-2644PREAI